Interestingly, myricitrin activated SOD and catalase and decreased TBARS concentrations in the liver, suggesting that it could help mitigate oxidative liver damage and aid in alleviating NAFLD. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.